Celgene Receives FDA Approval for INREBIC for Myelofibrosis

Press/Media: Press / Media

PeriodAug 16 2019

Media coverage

1

Media coverage

  • TitleCelgene Receives FDA Approval for INREBIC for Myelofibrosis
    Media name/outletInvesting News
    CountryCanada
    Date8/16/19
    PersonsRuben Mesa